Key result
Thoracoscopic LV lead implantation shows high safety with 0% in-hospital mortality or major complications.
Why the study?
Epicardial lead implantation is usually the second choice after failed coronary sinus cannulation for cardiac resynchronization therapy, but minimally invasive thoracoscopic lead implantation experience is limited.
Does minimally invasive surgical lead implantation using thoracoscopy provide safe and effective pacing in heart failure patients with failed coronary sinus cannulation?
Observational (n=17)
Does minimally invasive surgical lead implantation using thoracoscopy provide safe and effective pacing in heart failure patients with failed coronary sinus cannulation?
Thoracoscopic left ventricular lead implantation is a safe and feasible alternative for cardiac resynchronization therapy when coronary sinus cannulation fails.
Authors
No takes yet. Share an insight, caveat, or question.
Thoracoscopic LV lead implantation may be feasible after failed CS cannulation; hypothesis-generating and requires prospective validation before wider use.
Pojar et al. (2011) conducted an observational in Congestive heart failure (n=17). Minimally invasive surgical lead implantation using thoracoscopy was evaluated on In-hospital deaths or major co-morbidities. Minimally invasive left ventricular lead implantation using thoracoscopy was safe, with 0% in-hospital deaths or major co-morbidities and an acute threshold capture of 0.88 V/0.5 ms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: